Mark Penniston is the chief executive officer of Atorus Research. His career has centered on clinical analytics, statistical programming, and the technology that turns clinical-trial data into interpretable evidence.
Background
Penniston’s Atorus biography traces a succession of leadership roles through changes in ownership. He was senior vice president and general manager of clinical analytics at Theorem Clinical Research following its separation from Omnicare Clinical Research. After Chiltern acquired Theorem, he became executive vice president and general manager of clinical analytics and source.
When Chiltern became part of Covance, he led global functional service provider work as an executive vice president. His experience includes statistics, programming, clinical data management, data standards, and independent data monitoring. He holds bachelor’s and master’s degrees from the University of Massachusetts Amherst.
Clinical programming at Atorus
At Atorus, Penniston leads a business combining clinical services with open-source analytics and computing platforms. Ageirein brings R, SAS, Python, and Posit tools into a validated clinical environment, while OpenVal supports R-package validation. The company also provides custom installation and application engineering.
Those activities continue the same professional focus: helping clinical teams aggregate, analyze, and visualize their data while maintaining control over the systems used to produce it.
